Brochure / Flyer
01. Phase I Capabilities
Click here to download
02. Veeda Oncology Capabilities
03. Vaccine and Biosimilar Development Capabilities
04. Infectious Diseases Drug-development Solutions
05. Oncology - Large Molecule Capabilities
06. Phase 1 Trials Expertise | Veeda
07. Oncology- Small Molecules Development Capabilities
08. Veeda Group - Integrated Drug-development Services
09. Complex Generics and 505(b)(2) Whitepaper
10. Preclinical Drug Development Program
11. Aripiprazole LAI: An Overview of Veeda’s Approach to streamline Schizophrenia Drug Trials
12. Olaparib - An Overview of PARP Inhibitors and Clinical Trials
13. Veeda's Capabilities in Pazopanib Clinical Trials
14. Biostatistics and Clinical Trials Data Management
15. Determination of Free Doxorubicin and Liposomal Doxorubicin in K3EDTA Human Plasma
16. Trial Design for COVID Studies
01. Determination of Doxorubicin in Human Plasma
02. Approach for Quantitation of Iron in Human Serum Samples
